Association of HLA loci alleles and antigens in Saudi patients with vitiligo

Archives of Dermatological Research

Volumn 298, Issue 7, 2007, Pages 347-352

  Abanmi, Abdullah ^a   Harthi, Fahad Al ^a   Baqami, Riyadh Al ^a   Assaf, Saleh Al ^a   Zouman, Abdulrahman ^a   Arfin, Misbahul ^a   Tariq, Mohammad ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

HLA; Saudi; Vitiligo

Indexed keywords

HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA B7 ANTIGEN; HLA C ANTIGEN; HLA DQ1 ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; FEMALE; GENE FREQUENCY; GENE SEQUENCE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SAUDI ARABIA; STATISTICAL SIGNIFICANCE; VITILIGO;

EID: 33751186872     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-006-0699-4     Document Type: Article

References (35)

1. Al-Fouzan A, al-Arbash M, Fouad F, Kaaba SA, Mousa MA, al-Harbi SA (1995) Study of HLA classI/IL and T lymphocyte subsets in Kuwaiti vitiligo patients. Eur J Immunogenet 22(2):209-213
2. Alper CA, Boenisch T, Watson L (1972) Genetic polymorphism in human glycine-rich beta glycoprotein. J Exp Med 135:68-80
3. Amos DB, Pool P, Grier J (1980) HLA-A, HLA-B, HLA-C, and HLA-DR. In: Rose NR, Friedman H (eds) Manual of clinical immunology. American Society of Microbiology, Washington, DC, pp 978-986
4. Ando I, Chi HI, Nakagawa H, Otsuha F (1993) Difference in clinical features and HLA antigens between familial and nonfamilial vitiligo of non-segmental type. Br J Dermatol 129(4):408-410
5. Arcos-Burgos M, Parodi E, Salgar M, Bedya E, Buile J, Jaramillo D (2002) Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum Genet 110:334-342
6. Buc M, Busofa B, Hegyi E, Kolibasova K (1996) Vitiligo is associated with HLA-A2 and HLA-Dw7 in the Slovak populations. Folia Biol (Phraha) 42(1-2):23-25
7. Buc M, Fazekasova H, Cechova E, Hegyi E, Kolibasova K, Ferencik S (1998) Occurrence rates of HLA-DRB1, HLADQB1, and HLA-DPB1 alleles in patients suffering from vitiligo. Eur J Dermatol 8(1):13-15
8. Cui J, Harning R, Henn M, Bstryn JC (1992) Identification of pigment cell antigens defined by vitiligo antibodies. J Invest Dermatol 98(2):162-165
9. Dominguez-Soto L, Hojyo-Tomoka T, Vega-Memije E, Arenas R, Cores-Franco R (1994) Pigmentary problems in the tropics. Dermatol Clin 12(4):777-784
10. Dunston GM, Halder RM (1990) Vitiligo is associated with HLA-DR4 in black patients. A preliminary report. Arch Dermatol 126(1):56-60
11. Engleman EG, Grumet FC (1987) Influence of the HLA system on disease susceptibility. In: Fitz Patrick TB, Eisen AZ, et al (eds) Dermatology in general medicine, 3rd edn. McGraw-Hill, New York, pp 161-168
12. Finco O, Cuccia M, Martinetti M, Ruberto G, Orecchia G, Rabbiosi G (1991) Age of onset of vitiligo: relationship with HLA supratypes. Clin Genet 39(1):48-54
13. Fishman P, Azizi E, Shoenfeld Y, Sredni B, Yecheskel G, Ferrone S, Zigelman R, Chaitchik S, Floro S, Djaldetti M (1993) Vitiligo autoantibodies are effective against melanoma. Cancer 72(8):2365-2369
14. Foley LM, Lowe NJ, Misheloff E, Tiwari JL (1983) Association of HLA-DR4 with vitiligo. J Am Acad Dermatol 8(1):39-40
15. Hann S-K, Nordlund JJ (2000) Clinic features of generalized vitiligo. In: Hann S-K, Nordlund JJ (eds) The vitiligo. Blackwell, Oxford, pp 39-42
16. Harning R, Cui J, Bystryn JC (1991) Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol 97(6):1078-1080
17. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori (1992) T.Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T (eds) HLA 1991, vol 1. Oxford University Press, New York, pp 1065-1220
18. Le Poole IC, Das PK, Van den Wijngaard RM, Bos JD, Westerhof W (1993) Review of etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 2(4):145-153
19. Lorini R, Orecchia G, Maritinetti M, Dugoujon JM, Cuccia M (1992) Autoimmunity in vitiligo: relationship with HLA, Gm and Km polymorphisms. Autoimmunity 11(4):255-260
20. Mattiuz PL, Ihde D, Piazza A, Ceppellini R, Bodmer WF(1970) New approaches to the population genetics and segregation analysis of the HLA system. In: Terasaki PI (ed) Histocompatibility testing. Munksgaard, Kopenhagen
21. Metzker A, Zamir R, Gazit E, David M, Feurerman EJ (1980) Vitiligo and the HLA system. Dermatologica 160:100-105
22. Naughton GK, Reggiardo D, Bystryn JC (1986) Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol 15(5 Pt 1):978-981
23. Ollier W, Doyle P, Alonso A, Awad J, Williams E, Gill D, Welch S, Klouda P, Bacchus R, Festenstein H (1985) HLA polymorphisms in Saudi Arabs. Tissue Antigens 25(2):87-95
24. Orecchia G, Perfetti L, Malagoli P, Borghini F, Kipervarg Y (1992) Vitiligo is associated with a significant increase in HLA-A30, Cw6, and DQw3, and a decrease in C4AQ0 in northern Italian patients. Dermatology 185(2):123-127
25. Ortonne JP, Bose SK (1993) Vitiligo: where do we stand? Pigment Cell Res 6(2):61-72
26. Porter RR (1983) Complement polymorphism. The major histocompatibility complex and associated disease: a speculation. Mol Biol Med 1:161-168
27. Savejgaard A, Platz P, Ryder LP (1983) HLA and disease 1982-A survey. Immunol Rev 70:193-218
28. Schallreuter KU, Levenig C, Berger J (1991) Vitiligo and cutaneous melanoma. A case study. Dermatologica 183(4):239-245
29. Sheth KV, Edwards JA, Godwin JT (1985) Study of the HLA gene and antigen frequency from a Saudi Arabian Hospital. Tissue Antigens 25(3):156-162
30. Tastan HB, Akar A, Orkunoglu FE, Arca E, Inal A (2004) Association of class I antigens and HLA class II alleles with vitiligo in a Turkish population. Pigment Cell Res 17(2):181-184
31. Venkataram MN, White AG, Leeny WA, al Suwaid AR, Daar AS (1995) HLA antigens in Omani patients with vitiligo. Clin Exp Dermatol 20(1):35-37
32. Venneker GT, de Waal LP, Westerhof W, D'Amaro J, Schreuder GM, Asghar SS (1993) HLA associations in vitiligo patients in the Dutch population. Dis Markers 11(4):187-190
33. White AG, Lehny W, Kuchipudi P, Varghese M, Al Riyami H, Al Hashmi S, Daar AS (1999) Histocompatibility antigens in Omanis: comparison with other Gulf populations and implications for disease association. Ann Saudi Med 19(3):193-196
34. Zamani M, Spaepen M, Asghar SS, Huang C, Westerhof W, Nieweboer-Krobotova L, Cassiman JJ (2001) Linkage and association of HLA class II genes with vitiligo in Dutch population. BR J Dermatol 145(1): 90-94
35. Zhang XJ, Liu HS, Liang YH, Sun LD, Wang JY, Yang S, Liu JB, Gao M, He PP, Cui Y, Yang Q (2004) Association of HLA class I alleles with vitiligo in Chinese Hans. J Dermatol Sci 35(2):165-168